Korean J Nosocomial Infect Control.  2011 Dec;16(2):54-62.

Healthcare-Associated Infection Surveillance in Small and Medium Sized Hospitals

Affiliations
  • 1Infection Control Office, Severance Hospital, Korea.
  • 2Infection Control Office, Ajou University Hospital, Korea.
  • 3Infection Control Office, Ewha Womans University Mokdong Hospital, Korea.
  • 4Infection Control Office, The Catholic University of Korea, St. Vincent's Hospital, Korea.
  • 5Department of Quality Improvement, Gachon University Gil Hospital, Korea.
  • 6Infection Control Office, Korea University Guro Hospital, Korea.
  • 7Office of Infection Control, Gwandong University College of Medicine Myongji Hospital, Korea.
  • 8Department of Nursing, Youngdong University, Korea.
  • 9Department of Nursing, Semyung University, Korea.
  • 10Infection Control Office, Samsung Medical Center, Korea.
  • 11School of Clinical Nursing, University of Ulsan, Korea.
  • 12Department of Laboratory Medicine, Yonsei University, College of Medicine, Korea.
  • 13Department of Internal Medicine, Gwangmyung Sungae Hospital, Korea.
  • 14Devision of Infectious Disease, Korea University College of Medicinel, Korea.
  • 15Devision of Infectious Disease, Gachon University of Medicine and Science, Korea.
  • 16Infection Control Office, Seoul National University Hospital, Korea.
  • 17Department of Internal Medicine, Kangbuk Samsung Hospital, Korea.
  • 18Department of Laboratory Medicine, Seoul National University College of Medicine, Korea. euichong@snu.ac.kr

Abstract

BACKGROUND
The purpose of this study is to know the healthcare-associated infection (HAI)s in small and medium sized hospitals, less than 400 beds.
METHODS
We had web based surveillance for HAIs in 27 hospitals from August to October 2010. The surveillance performed in 1-2 ICUs and 1 general ward in each hospitals by CDC definition. And for the multi-drug resistant organisms (MDROs), we reviewed all of blood culture results.
RESULTS
We identified 319 HAIs among 269,436 patients days. The HAIs rate was 1.18 (CI 1.05-1.32)/1,000 patient-days. Urinary tract infection was the most common HAI (52.4%) in this study followed by pneumonia (18.9%), blood-stream infections (14.2%), surgical site infection (7.9%), and others (6.6%). There were 76.5% of device associated infections in UTI, 46.7% in BSI, and 18.3% in pneumonia. The rate of HAIs in ICU was higher than that of in general ward (4.6 vs 0.9/1,000 patient-days). However, the indwelling catheter associated urinary tract infection rate was lower in ICU (2.6 vs 4.4/1,000 device days). There were no significant differences in central line-associated blood stream infection rate (1.5 vs 1.8) and ventilator-associated pneumonia rate (3.0 vs 0.0). The common microorganisms found in HAIs were Escherichia coli (19.8%), Staphylococcus aureus (13.1%), and Pseudomonas aeruginosa (12.7%). Moreover, 90.9% of S. aureus were resistant to methicillin, and 38.2% of P. aeruginosa and 44.4% of Acinetobacter baumannii were resistant to imipenem. Total of 66 MDROs were isolated from blood culture and the result shows that the MRSA was 84.6% (56 case), carbapenmen-resistant Acinetobacter spp. was 10.6% (7 case), and vancomycin-resistant enterococci was 4.6% (3 case).
CONCLUSION
The characteristics of HAIs in small and medium sized hospitals will be contributed to the decision making of governance policy for infection control and to provide comparable data for these hospitals.

Keyword

Small hospital; Healthcare-associated infection; ICU; Multidrug resistant organisms

MeSH Terms

Acinetobacter
Acinetobacter baumannii
Catheters, Indwelling
Centers for Disease Control and Prevention (U.S.)
Decision Making
Escherichia coli
Humans
Imipenem
Infection Control
Methicillin
Methicillin-Resistant Staphylococcus aureus
Patients' Rooms
Pneumonia
Pneumonia, Ventilator-Associated
Pseudomonas aeruginosa
Rivers
Staphylococcus aureus
Urinary Tract Infections
Imipenem
Methicillin
Full Text Links
  • KJNIC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr